Clinical Trials Directory

Trials / Completed

CompletedNCT02195921

Acupuncture for Chemotherapy-Induced Nausea and Vomiting

Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Tianjin University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to clarify whether the matching acupoints is more effective than a single point by electroacupuncture in the management of chemotherapy-induced nausea and vomiting .

Detailed description

Patients were assigned to Four sessions of electroacupuncture(EA) at the CV12, ST36, CV12+ST36 acupoints or antiemetic therapy over 5 days. primary and secondary outcomes and Adverse Eventswill be assessed.

Conditions

Interventions

TypeNameDescription
OTHERsingle point Zhongwan(CV12) plus antiemetic drugAll participants were supine in the hospital bed. A disposable sterile acupuncture needle (ø 0.30 × 40 mm, Hwato) was inserted vertically at approximately 20-30 mm until "De Qi" (sensation of soreness, numbness, distension, etc. around the acupoint) was reported by the participants. Then, the needle handle was clamped via a metal clip to connect to the positive electrode of the electric acupuncture apparatus (Huatuo, SDZ-V model, Suzhou Medical Appliance). Another reference electrode was placed 1 cm above the CV12 acupoints of the stimulation point, where no acupoints or meridians passed through. A dilatational wave at a frequency of 2/10 Hz and a current intensity at the highest level tolerated by the patient, with a maximum intensity no more than 10 mA, were used to deliver the EA stimulation. People in the intervention groups were offered a standardized 30-minute EA session once daily from the 1st day of the four-day chemotherapy cycle.
OTHERsingle point Zusanli(ST36) plus antiemetic drugA disposable sterile acupuncture needle (ø 0.30 × 40 mm, Hwato) was inserted vertically at approximately 20-30 mm until "De Qi" (sensation of soreness, numbness, distension, etc. around the acupoint) was reported by the participants. Then, the needle handle was clamped via a metal clip to connect to the positive electrode of the electric acupuncture apparatus (Huatuo, SDZ-V model, Suzhou Medical Appliance). Another reference electrode was placed 1cm below ST36 acupoints of the stimulation point, respectively, where no acupoints or meridians passed through. A dilatational wave at a frequency of 2/10 Hz and a current intensity at the highest level tolerated by the patient, with a maximum intensity no more than 10 mA, were used to deliver the EA stimulation. People in the intervention groups were offered a standardized 30-minute EA session once daily from the 1st day of the four-day chemotherapy cycle.
OTHERZusanli(ST36)and Zhongwan(CV12) plus antiemetic drugStimulating both Zusanli(ST36)and Zhongwan(CV12)
DRUGonly antiemetic drugreceived routine antiemetic treatment

Timeline

Start date
2015-04-01
Primary completion
2016-03-01
Completion
2017-01-01
First posted
2014-07-21
Last updated
2021-02-11
Results posted
2021-02-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02195921. Inclusion in this directory is not an endorsement.